🇺🇸 FDA
Patent

US 10226518

Ubiquitinylated proteins

granted A61KA61K2039/5154A61K39/0011

Quick answer

US patent 10226518 (Ubiquitinylated proteins) held by Providence Health & Science—Oregon expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Providence Health & Science—Oregon
Grant date
Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5154, A61K39/0011, A61P, A61P31/00